Wilding G - Search Results

1

Qualitative radiology assessment of tumor response: does it measure up?

Gottlieb RH, Litwin A, Gupta B, Taylor J, Raczyk C, Mashtare T, Wilding G, Fakih M. Gottlieb RH, et al. Among authors: wilding g. Clin Imaging. 2008 Mar-Apr;32(2):136-40. doi: 10.1016/j.clinimag.2007.11.001. Clin Imaging. 2008. PMID: 18313578

2

A phase II study of first-line biweekly capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer.

Puthillath A, Mashtare T Jr, Wilding G, Khushalani N, Steinbrenner L, Ross ME, Romano K, Wisniewski M, Fakih MG. Puthillath A, et al. Among authors: wilding g. Crit Rev Oncol Hematol. 2009 Sep;71(3):242-8. doi: 10.1016/j.critrevonc.2008.10.012. Epub 2008 Dec 10. Crit Rev Oncol Hematol. 2009. PMID: 19081732 Clinical Trial.

3

Intensive radiographic and biomarker surveillance in stage II and III colorectal cancer.

Fora A, Patta A, Attwood K, Wilding G, Fakih M. Fora A, et al. Among authors: wilding g. Oncology. 2012;82(1):41-7. doi: 10.1159/000333855. Epub 2012 Jan 26. Oncology. 2012. PMID: 22286543

4

Safety and efficacy of first-line chemotherapy in unresected metastatic colorectal cancer.

Puthillath A, Dunn KB, Rajput A, Smith J, Yang G, Wilding GE, Tan W, Gupta B, Fakih MG. Puthillath A, et al. Among authors: wilding ge. Clin Colorectal Cancer. 2007 Nov;6(10):710-5. doi: 10.3816/CCC.2007.n.040. Clin Colorectal Cancer. 2007. PMID: 18039424

5

Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II-III colorectal cancer.

Angitapalli R, Litwin AM, Kumar PR, Nasser E, Lombardo J, Mashtare T, Wilding GE, Fakih MG. Angitapalli R, et al. Among authors: wilding ge. Oncology. 2009;76(5):363-8. doi: 10.1159/000210025. Epub 2009 Mar 25. Oncology. 2009. PMID: 19321964

6

Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma.

Ailawadhi S, Abdelhalim AN, Derby L, Mashtare TL, Miller KC, Wilding GE, Alberico RA, Gottlieb R, Klippenstein DL, Lee K, Chanan-Khan AA. Ailawadhi S, et al. Cancer. 2010 Jan 1;116(1):84-92. doi: 10.1002/cncr.24704. Cancer. 2010. PMID: 19862816 Free article. Clinical Trial.

7

Cetuximab-induced hypomagnesemia in patients with colorectal cancer.

Fakih MG, Wilding G, Lombardo J. Fakih MG, et al. Among authors: wilding g. Clin Colorectal Cancer. 2006 Jul;6(2):152-6. doi: 10.3816/CCC.2006.n.033. Clin Colorectal Cancer. 2006. PMID: 16945172

8

Stop and go FOLFOX plus bevacizumab chemotherapy in the first-line treatment of metastatic colorectal cancer.

Vaidyanathan G, Groman A, Wilding G, Fakih MG. Vaidyanathan G, et al. Among authors: wilding g. Oncology. 2010;79(1-2):67-71. doi: 10.1159/000319549. Epub 2010 Nov 12. Oncology. 2010. PMID: 21071992

9

High-dose octreotide acetate for management of gastroenteropancreatic neuroendocrine tumors.

Chadha MK, Lombardo J, Mashtare T, Wilding GE, Litwin A, Raczyk C, Gibbs JF, Kuvshinoff B, Javle MM, Iyer RV. Chadha MK, et al. Anticancer Res. 2009 Oct;29(10):4127-30. Anticancer Res. 2009. PMID: 19846960 Free article.

10

5-fluorouracil, leucovorin and oxaliplatin plus bevacizumab in the first-line treatment of metastatic colorectal cancer: a single-institute study.

Bir A, Tan W, Wilding GE, Lombardo J, Fakih MG. Bir A, et al. Among authors: wilding ge. Oncology. 2007;72(1-2):4-9. doi: 10.1159/000110546. Epub 2007 Oct 30. Oncology. 2007. PMID: 17971679

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

550 results

Search Page

Filters